MedPath

Role of the Ketogenic Diet in Women With PCOS

Not Applicable
Not yet recruiting
Conditions
Polycystic Ovary Syndrome
Interventions
Combination Product: caloric diet with Metformin
Behavioral: ketogenic diet
Behavioral: caloric diet
Registration Number
NCT04175964
Lead Sponsor
National Research Centre, Egypt
Brief Summary

For the fact of PCOS symptoms could be improved with weight loss and improving insulin resistance, the investigators will do this study to evaluate the role of the ketogenic diet in overweight and obese women with PCOS.

Detailed Description

Polycystic ovary syndrome (PCOS) is one of the most common endocrinal abnormalities that affect females within the reproductive age, and are found in about 4% of women. PCOS is commonly associated with symptoms of increased testosterone such as irregular or absent menstrual cycle, increased body hair, and infertility. PCOS is also associated with other disorders such as obesity, insulin resistance, hyperinsulinemia, diabetes mellitus type 2, and dyslipidemia.

Until now, there is no known curative treatment for PCOS. However, anti-diabetic medications can improve many metabolic disorders such as insulin resistance, and increased levels of serum testosterone and total cholesterol. In addition, regulation of diet with exercise could improve the insulin sensitivity. Therefore, managements that aim to decrease the insulin level, improve the insulin resistance and decrease the body weight may be useful for improving symptoms of PCOS.

Ketogenic diets are characterized by a reduction in carbohydrates (usually to less than 50 g/day) and a relative increase in the proportions of protein and fat. People following the keto diet gain 75% of their calories from fat, 20% from protein, and 5% from carbohydrates. Previous studies have revealed that the ketogenic diet of low carbohydrate could decrease the body weight and improve the insulin resistance.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
Female
Target Recruitment
240
Inclusion Criteria
  1. Age range between 16-35 years.

  2. BMI ≥ 27.

  3. Normal Renal Function.

  4. Rotterdam criteria for the diagnosis of polycystic ovary syndrome:

    • Oligo/anovulation
    • Hyperandrogenism
    • Polycystic ovaries on ultrasound.
Exclusion Criteria
  1. Age <16 or >35 years.
  2. BMI < 27.
  3. Pregnancy.
  4. Major medical disorders or other concurrent medical illnesses e.g. DM, other causes of androgen excess and hypercholesteremia
  5. Current or previous use of hormonal, anti-diabetic or anti-obesity drugs, or other drugs that affect hormone levels, carbohydrate metabolism or appetite.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group 2caloric diet with MetforminPCO patients that will receive caloric diet with Metformin
Group 1ketogenic dietPCO patients that will receive ketogenic diet only
Group 3caloric dietPCO patients that will receive caloric diet only
Primary Outcome Measures
NameTimeMethod
Role of the ketogenic diet in restoring normal ovulation that will be assessed by serial transvaginal ultrasound.8 weeks

To evaluate the role of the ketogenic diet in overweight and obese women with PCOS regarding ovulation that will be assessed by serial transvaginal ultrasound.

comparison between ketogenic diet, caloric diet and caloric diet with Metformin regarding ovulation that will be assessed by serial transvaginal ultrasound.8 weeks

comparison between ketogenic diet, caloric diet and caloric diet with Metformin regarding ovulation that will be assessed by serial transvaginal ultrasound.

Secondary Outcome Measures
NameTimeMethod
Role of the ketogenic diet in the affection of testosterone level8 weeks

To evaluate the role of the ketogenic diet in the affection of testosterone level in overweight and obese women with PCOS

comparison between ketogenic diet, caloric diet and caloric diet with Metformin regarding testosterone level8 weeks

comparison between ketogenic diet, caloric diet and caloric diet with Metformin regarding testosterone level

© Copyright 2025. All Rights Reserved by MedPath